## Abstract The role of age at menarche and at menopause on epithelial ovarian cancer risk was reβassessed in a combined analysis of 3 hospitalβbased caseβcontrol studies conducted in Italy, the United Kingdom and Greece, which produced a total of 1, 140 cases and 2,724 controls. In the overall dat
Diet and thyroid cancer: A pooled analysis of four european case-control studies
β Scribed by Silvia Franceschi; Fabio Levi; Eva Negri; Ambrogio Fassina; Carlo La Vecchia
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- French
- Weight
- 486 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The primary risk factor for bladder cancer is cigarette smoking. Using a combined analysis of 11 case-control studies, we have accurately measured the relationship between cigarette smoking and bladder cancer in men. Available smoking information on 2,600 male bladder cancer cases and 5,524 male con
In a hospital-based case-control study of common malignant epithelial tumors of the ovary, conducted in Athens (1989)(1990)(1991), 189 cases were compared with 200 hospital visitor controls. Personal interviews were conducted in all cases and diet was ascertained through a semi-quantitative food fre
A case-control study of diet and stomach cancer was conducted in Ankara, Turkey, between December 1987 and March 1988. One hundred patients with adenocarcinoma of the stomach were matched with 100 control subjects according to age, sex, and residential area. A dietary questionnaire was administered
To assess the dietary correlates of cancer of the ovary, the consumption of a wide range of food groups has been investigated in a case-control study conducted between January 1992 and September 1999 in 4 Italian areas. Cases were 1,031 women with incident, histologically confirmed epithelial ovaria
The nutritional aetiology of prostate cancer was evaluated in Athens, Greece, through a case-control study that included 320 patients with histologically confirmed incident prostate cancer and 246 controls without history or symptomatology of benign prostatic hyperplasia or prostate cancer, treated